Natural killer cell recognition of HLA class I molecules

Reviews in Immunogenetics

Volumn 2, Issue 3, 2000, Pages 433-448

  Brooks, A G ^a   Boyington, J C ^b   Sun, P D ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

CD94 NKG2; HLA; KIR; Natural killer cell; Receptors; Structure

Indexed keywords

CD94 ANTIGEN; CELL SURFACE RECEPTOR; HLA ANTIGEN CLASS 1; HLA C ANTIGEN; HLA E ANTIGEN; LIGAND; PEPTIDE; ZINC ION;

ALLELE; ALLOTYPE; ALPHA HELIX; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; BINDING SITE; CELL SPECIFICITY; CRYSTAL STRUCTURE; HUMAN; LIGAND BINDING; MOLECULAR INTERACTION; MUTAGENESIS; NATURAL KILLER CELL; NONHUMAN; PROTEIN PROTEIN INTERACTION; REVIEW; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANTIGENS, CD; ANTIGENS, CD94; BINDING SITES; CYTOTOXICITY, IMMUNOLOGIC; DIMERIZATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-C ANTIGENS; HUMANS; HYDROGEN BONDING; LECTINS, C-TYPE; MACROMOLECULAR SUBSTANCES; MEMBRANE GLYCOPROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IMMUNOLOGIC; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; STRUCTURE-ACTIVITY RELATIONSHIP; ZINC;

EID: 0034520987     PISSN: 13981714     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (136)

1. Biology of natural killer cells
2. The Fc receptor for IgG on human natural killer cells: Phenotypic, functional, and comparative studies with monoclonal antibodies
3. Natural killer susceptibility of human cells may be regulated by genes in the HLA region on chromosome 6
4. NK susceptibility varies inversely with target cell class I HLA antigen expression
5. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism
6. In search of the 'missing self': MHC molecules and NK cell recognition
7. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells
8. Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely correlated with HLA class I antigen expression
9. Ly-49 multigene family expressed by IL-2-activated NK cells
10. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties
11. A family of murine NK cell receptors specific for target cell MHC class I molecules
12. The Ly-49D receptor activates murine natural killer cells
13. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein
14. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes
15. CD69-mediated pathway of lymphocyte activation: Anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta
16. CD69-triggered ERK activation and functions are negatively regulated by CD94/NKG2-A inhibitory receptor
17. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells
18. Cutting edge: Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP
19. NKR-P1, a signal transduction molecule on natural killer cells
20. cDNA cloning of mouse NKR-P1 and genetic linkage with LY-49. Identification of a natural killer cell gene complex on mouse chromosome 6
21. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes
22. An activating immunoreceptor complex formed by NKG2D and DAP10
23. Activation of NK cells and T cells by NKG2D, a receptor for stress- inducible MICA [see comments]
24. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis
25. Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity
26. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells
27. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
28. Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells
29. Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells
30. 2B4 functions as a co-receptor in human NK cell activation
31. Susceptibility or resistance to lysis by alloreactive natural killer cells is governed by a gene in the human major histocompatibility complex between BF and HLA-B
32. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2- specific natural killer cells
33. Surface molecules involved in CD3-negative NK cell function. A novel molecule which regulates the activation of a subset of human NK cells
34. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition
35. Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: Definition of five distinct NK-determined allospecificities in humans
36. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones
37. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules
38. NKB1: A natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules
39. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor
40. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor
41. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibility complex haplotype
42. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells
43. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains
44. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes
45. A human killer inhibitory receptor specific for HLA-A1,2
46. The natural killer cell receptor specific for HLA-A allotypes: A novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer
47. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors
48. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor
49. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
50. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts
51. P49, a putative HLA-G1 specific inhibitory NK receptor belonging to the immunoglobulin superfamily
52. p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily
53. NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains
54. Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors
55. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes
56. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition
57. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules
58. Definition of polymorphic residues on killer Ig-like receptor proteins which contribute to the HLA-C binding site
59. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors
60. Genomic organization of a human killer cell inhibitory receptor gene
61. The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster
62. Plasticity in the organization and sequences of human KIR/ILT gene families
63. Cutting edge: KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties
64. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand [In Process Citation]
65. Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2
66. Structure of a human natural killer cell inhibitory receptor
67. Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I
68. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2
69. Peptide-induced modulation of target cell sensitivity to natural killing
70. Peptide specificity in the recognition of MHC class I by natural killer cell clones
71. A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705
72. Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells
73. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity
74. Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis
75. Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene
76. Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: Requirement for all three p70 immunoglobulin domains
77. The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells
78. Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule
79. Zinc bound to the killer cell-inhibitory receptor modulates the negative signal in human NK cells
80. The human natural killer cell immune synapse
81. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody
82. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody
83. Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles
84. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells
85. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1
86. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes
87. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen
88. Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses
89. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits
90. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor
91. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules
92. The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene
93. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells
94. Isolation and characterization of NK cell or NK/T cell-specific cDNA clones
95. Molecular characterization of human CD94: A type II membrane glycoprotein related to the C-type lectin superfamily
96. Cloning of NKG2-F, a new member of the NKG2 family of human natural killer cell receptor genes
97. Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer
98. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C
99. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: Evidence for receptor function in heterologous transfectants
100. Natural killer lectin-like receptors have divergent carboxy-termini, distinct from C-type lectins
101. A multigene family on human chromosome 12 encodes natural killer-cell lectins
102. Association of DAP12 with activating CD94/NKG2C NK cell receptors
103. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice
104. Structure of CD94 reveals a novel C-type lectin fold: Implications for the NK cell-associated CD94/NKG2 receptors
105. Structure of the calcium-dependent lectin domain from a rat mannose-binding protein determined by MAD phasing
106. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand
107. Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E
108. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E
109. Reconstitution of bacterial expressed human CD94: The importance of the stem region for dimer formation
110. Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E
111. HLA-E. A novel HLA class I gene expressed in resting T lymphocytes
112. The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein
113. Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissue
114. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide
115. Impaired intracellular transport and cell surface expression of nonpolymorphic HLA-E: Evidence for inefficient peptide binding
116. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences
117. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9
118. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: Preferential response to an HLA-G-derived nonamer
119. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
120. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
121. Inhibitory and activating receptors involved in immune surveillance by human NK and myeloid cells
122. Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamily
123. The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: Analysis of LIR-1 + NK cell clones
124. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18
125. Human myeloid cells express an activating ILT receptor (ILT1) that associates with Fc receptor gamma-chain
126. Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction
127. Allele and locus-specific differences in cell surface expression and the association of HLA class I heavy chain with beta 2-microglobulin: Differential effects of inhibition of glycosylation on class I subunit association
128. Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA
129. Divergent functions of lectin-like receptors on NK cells
130. Identification of a human member of the Ly-49 multigene family
131. Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans
132. Human diversity in killer cell inhibitory receptor genes
133. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells
134. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40
135. Cutting edge: The human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis
136. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP